As outlined by the company towards the end of 2013 below -
PAT-SM6
Q1 o Final results from MM trial
1H o Complete GMP manufacturing
TBA o Commence combination Phase I/II MM trial with Onyx
PAT-LM1
o Complete manufacturing and scale-up work / Toxicology
o Preclinical data published
PAT-SC1
o Out-licensing deal
Discovery Abs:
o Target work on PAT-SM3 & PAT-NM1
2014.... your thoughts and predictions, page-4
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |